Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7306)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2021 (publication date) through Nov 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li XH, Huang YY, Lu LM, Zhao LJ, Luo XK, Li RJ, Dai YY, Qin C, Huang YQ, Chen H. Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori. World J Gastroenterol 2021; 27(24): 3595-3608 [PMID: 34239272 DOI: 10.3748/wjg.v27.i24.3595] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3595.htm |
| Number | Citing Articles |
| 1 |
Mohammad Sholeh, Saeed Khoshnood, Taher Azimi, Jasem Mohamadi, Vahab Hassan Kaviar, Marzieh Hashemian, Somayeh Karamollahi, Nourkhoda Sadeghifard, Hedayat Heidarizadeh, Mohsen Heidary, Morteza Saki. The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis. PeerJ 2023; 11: e15121 doi: 10.7717/peerj.15121
|
| 2 |
Meng Li, Ning Gao, Shaoli Wang, Yufeng Guo, Zhen Liu. Bibliometric analysis of Helicobacter pylori resistance—from 2002 to 2022. Helicobacter 2023; 28(4) doi: 10.1111/hel.12983
|
| 3 |
Mulan Li, Ying Liu, Youhuan Gong, Xiaojie Yan, Le Wang, Wenfu Zheng, Hao Ai, Yuliang Zhao. Recent advances in nanoantibiotics against multidrug-resistant bacteria. Nanoscale Advances 2023; 5(23): 6278 doi: 10.1039/D3NA00530E
|
| 4 |
Xingsheng Zuo, Qingli Shen, Jing Luo, Yaqin Wang, Chenglong Zhao. Clarithromycin sustained-release tablet may be an improper therapy for the eradication of Helicobacter pylori. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241275332
|
| 5 |
Mina Akbarirad, Ladan Goshayeshi, AmirAli Moodi Ghalibaf, Hassan Mehrad Majd, Ghasem Soleimani, Rana Kolahi Ahari. Helicobacter pylori Standard Triple Therapy Outcomes in Iranian Population: A Retrospective Population-based Study in Mashhad, Northeast of Iran. Jundishapur Journal of Microbiology 2022; 15(10) doi: 10.5812/jjm-127842
|
| 6 |
坷娜 王. Progress on Drug Resistance Mechanism of Helicobacter pylori. Advances in Clinical Medicine 2023; 13(07): 10694 doi: 10.12677/ACM.2023.1371493
|
| 7 |
Naim Asyraf Rosli, Anis Rageh Al-Maleki, Mun Fai Loke, Eng Guan Chua, Mohammed Abdelfatah Alhoot, Jamuna Vadivelu. Polymorphism of virulence genes and biofilm associated with in vitro induced resistance to clarithromycin in Helicobacter pylori. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00579-4
|
| 8 |
Meng Li, Ning Gao, Shao-Li Wang, Yu-Feng Guo, Zhen Liu. Hotspots and trends of risk factors in gastric cancer: A visualization and bibliometric analysis. World Journal of Gastrointestinal Oncology 2024; 16(5): 2200-2218 doi: 10.4251/wjgo.v16.i5.2200
|